期刊文献+

应用HPV和液基细胞筛查内蒙古杭锦旗宫颈病变的研究 被引量:4

Reseuvch on cerrical diseose by HPV and tiuid based cytology in Inner Mongolia Hang jing pi
暂未订购
导出
摘要 评估宫颈癌筛查方法,探讨少数民族地区宫颈病变发病情况。方法:2010年3月24日~2010年3月30日,在当地政府大力支持下,由当地妇幼保健院组织常住鄂尔多斯杭锦旗2013名年龄在25-65岁已婚有户籍的妇女进行宫颈癌筛查。采用第二代杂交捕获人乳头瘤病毒(HC-Ⅱ)和宫颈薄层液基细胞学(TCT)检测,对宫颈细胞异常和HC-Ⅱ阳性者进行阴道镜检查,阴道镜异常者行多点活检或宫颈管诊刮术,以病理学诊断为金标准。比较3种方法的检出率,评价TCT,HPV的诊断价值。结果:2013例受检者中,TCT异常患者258例,占12.82%;HPV-DNA阳性者,481例,占23.89%,在阴道镜下行多点活检,病理结果 CINⅠ以上者191例,占9.49%.TCT和HPV均阴性者,属于无病理改变。TCT(-),HPV(+)者中≥CINⅡ的检出率13.33%(2/15),TCT(+)和HPV(+)同时存在的病例中,CINⅡ的检出率最高占39.32%(46∕117),仅TCT(+)而HPV(-)者,占13.60%(8/59),8例均为CINⅡ,无原位癌和浸润癌发生。P<0.05差异有统计学意义。结论:持续的HR-HPV感染与宫颈病变的演进有关,TCT联合HC-Ⅱ是宫颈癌筛查最有效的方法,尤其对宫颈高度病变,可以有效的预防宫颈癌的发生。 Objective: Assessment of cervical cancer screening methods, in minority region in cervical disease incidence:Method: March 24, 2010 - 30 day in the local government support energetically below, by the local maternal and child health care hospital for years the organization of Erdos banner 2013 age in the 25 -65 years old married a domicile in women undergoing cervical screening, the cervical liquid based thin -layer cell ( TCT ) ; HC - II ( hybrid capture, two generation) for quantitative detection of cervical HPV - DNA content, on cervical cell abnormalities and HPV - DNA positive subjects undergoing eolposcopy, colposcopic abnormalities underwent multiple biopsy and endocervical curettage, the pathological diagnosis as the gold standard. Comparison of three methods of detection, evaluation of TCT, HPV diagnosis value. Resalts : 2013 cases of abnormal TCT by pick- ing up, in 258 cases, accounting for 12.82% ; HPV - DNA positive, 481 cases, 23.89%, in a colposcopy downlink multiple bi- opsy. Pathological findings of more than CIN in 191 cases , accounting for 9.49% of;TCT and HPV were all negative, no patho- logical changes. TCT ( - ), HPV ( + ) ~CIN II in detection rate of 13.33% (2/15), TCT and HPV ( + ) exist at the same time case, CIN the highest detection rate accounted for 39.32% (46/117), TCT ( + ) ,HPV ( - ), 13.60% (8/59), 8 cases were CIN II, carcinoma in situ and invasive cancer without. There were statistically significant differences in P 〈 0.05. Conclusion : High ris HPV infection is related to cervical lesion progress , cervical liquid based thin -layer cell (TCT) combined with HC -II (hybrid capture two generation) in cervical cancer screening are the most effective method, can be found in cervical lesion height, effective in the prevention of cervical cancer.
出处 《中国民族医药杂志》 2012年第12期65-68,共4页 Journal of Medicine and Pharmacy of Chinese Minorities
关键词 宫颈癌筛查 宫颈液基细胞学检查 人乳头瘤病毒 鄂尔多斯杭锦旗 Cervical cancer screening cervical liquid based cytology HPV Erdos HangJinqi
  • 相关文献

参考文献11

  • 1Li LD, Lu FZ, Zhang SW, Zhang SW, Mu R, Sun SD, Huangpu XM, Sun J, Zhou YS, Ouyang NH, Rao KQ, Chen YD, et al. Cancer mortality trends in the People's Republic of China: 1973 -1992. Chinese J Oneol 1997,19:3 -9.
  • 2郎景和.迎接子宫颈癌预防的全球挑战与机遇[J].中华妇产科杂志,2002,37(3):129-131. 被引量:883
  • 3Davey DD, Nielsen ML , Rosenstock W , et al. Tepmionlogy and specinmen adequacy in cervicovaginal cytoulogy: the college of American pathologists interlaboratory comparison program experience[J]. Arch Pathol Lab Med, 1992,116 : 903 - 907.
  • 4乔友林 章文华 赵方辉etal.子宫颈癌筛查及早诊早治[J].中国肿瘤,2000,9(9):541-541.
  • 5中国医学科学院肿瘤研究所肿瘤医院子宫颈癌协作组,襄垣县妇幼保健院子宫颈癌协作组,戎寿德,赵方辉.子宫颈癌筛查方法的比较研究简介[J].中国肿瘤,2000,9(9):389-390. 被引量:8
  • 6I Zur H. Papillomavirus infectiona major cause of hunmn canc- ers[J]. Biochem Biophys Acta,1996,1288(2) :55 -88.
  • 7Smith J S , Lindsay L , Hoot s B , et al. Human papillo- mavirus typedist ribution in invasive cervical cancer and high - grade cervical lesions :A meta - analysis update [ J ] . Int J Cancer, 2007 , 121(3) :621 - 632.
  • 8Monsonego J. Cervical cancer prevention : t he impact of HPVvaccination[ J ] . Gynecol Obstet Fertil , 2006,34 (3) :189 -201.
  • 9Allan BR , Marais DI Denny L , et al. The agreement be- tween cervical abnormalities ident - ified by cytology and detection of high - risk types of human papillomavirus [J]. S Mr Med J ,2006,96(11) :1186.
  • 10Lonky NM, Navarre GL, Saunders S, et al. Low - grade Papanicolar smear and the Bethesda system : a prospective cytohistopathologic analysis [ J ]. Obstet Gynecol, 1995,85 (Spt I ) :716 -721.

二级参考文献6

  • 1乔友林.子宫颈癌预防研究的里程碑[J].基础医学与临床,2006,26(12):1293-1295. 被引量:22
  • 2屠铮,李静,赵超,宋丹,崔淑慧,章文华,乔友林,Belinson JL,魏丽惠.醋白肉眼观察试验在宫颈病变筛查中的价值[J].中国妇产科临床杂志,2007,8(2):90-92. 被引量:25
  • 3李连弟,陈育德.见:全国肿瘤防治研究办公室,中国恶性肿瘤死亡调查研究(1990-1992).北京:人民卫生出版社,2008:149,443.
  • 4Zhao FH, Lin MJ, Chen F, et al. Performance of high- risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population - based studies from China. Lancet Oncol, 2010, 11: 1160-1171.
  • 5Qiao YL, Sellors JW, Eder PS, et al. A new HPV- DNA test for cervical - cancer screening in developing regions: a cross- sectional study of clinical accuracy in rural China. Lancet Oncol, 2008, 9: 929-936.
  • 6赵方辉,胡尚英,王少明,陈凤,张询,章文华,潘秦镜,乔友林.高危型人乳头瘤病毒载量与子宫颈病变的关系[J].中华预防医学杂志,2009,43(7):565-570. 被引量:45

共引文献894

同被引文献35

  • 1李隆玉,乔志强,张敏芳,杨建平,鲍彦平,安云婷,雷钧,熊楠华,于晓红,张洵,潘秦镜,乔友林.多种检测方法在子宫颈癌及癌前病变筛查中的应用评估[J].中华流行病学杂志,2007,28(10):964-967. 被引量:35
  • 2Behtash N,Mehrdad N.Cervical cancer:screening and prevention[J].Asian Pac J Cancer Prev,2006,7(4):683-686.
  • 3SiddiqaA, Zainab M, Qadri I, et al. Prevalence and genotyping of high risk human papillomavirus in cervi- cal cancer samples from punjab, pakistan [J]. Viruses, 2014, 6(7):2762-2767.
  • 4Berman NR. Cervical cancer screening today. The role of HPV DNA testing [J]. Advance For Nurse Practition- ers, 2006, 14(4):24-29.
  • 5Bray F, Ren JS, Masuyer E, et al. Global estimates of cancerprevalence for 27 sites in the adult population in 2008[J]. Int J Cancer, 2013, 132(5):1133-1145.
  • 6Yildirim JG, Arabaci Z. Innovations in HPV vaccination and roles of nurses in cervical cancer prevention [J]. Asian Pac J Cancer Prev, 2014, 15(23):10053-10056.
  • 7Demir F, Kimiloglu E, Igdem AA, et al. High risk HPV in situ hybridization, p16 INK 4A, and survivin expres- sions in cervical carcinomas and intraepithelial neo- plasms evaluation of prognostic factors [J]. Eur J Gy- naecol Oncol, 2014, 35(6):708-717.
  • 8Ronco G, Dillner J, Elfstr6m KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised con- trolled trials[J]. The Lancet, 2014, 383(9916):524-532.
  • 9Canales NA, Marina VM, Castro JS, et al. A1BG and C3 are overexpressed in patients with cervical intraep- ithelial neoplasia lU [J]. Oncol Lett, 2014, 8(2):939-947.
  • 10Park JS, Kim YT, Lee A, et al. Prevalence and type dis- tribution of human papillomavirus in cervicall adenocar- cinoma in Korean womenn [J]. Gynecol Oncol, 2013, 130(1):115-120.

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部